美股市場個股詳情
SNSE Sensei Biotherapeutics
- 1.020
- +0.020+1.99%
收盤價 04/26 16:00 (美東)
2557.24萬總市值-836市盈率TTM
1.040最高價1.000最低價6161股成交量1.040今開1.000昨收6274.34成交額0.04%換手率虧損市盈率(靜)2507.10萬總股本1.72052周最高0.39市淨率1673.87萬流通值0.51052周最低--股息TTM1641.05萬流通股26.500歷史最高--股息率TTM4.00%振幅0.510歷史最低1.018平均價1股每手
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
Sensei Biotherapeutics股票討論區
Biotherapeutics Company Announces Revolutionary Cancer Treatment Development
In the ongoing battle against cancer, groundbreaking research and innovative treatments are the beacons of hope for patients worldwide. One such beacon shines brightly from the laboratories of Sensei Biotherapeutics, Inc., a clinical-stage immuno-oncology company dedicated to the discovery and development of next-gen...
NEWS
Sensei Biotherapeutics, Inc. (SNSE) announces the publication of a research paper in Nature Communications detailing the development of SNS-101, a pH-sensitive monoclonal antibody targeting VISTA to suppress T-cell activation in cancer patients. The paper highlights the unique mechanism of SNS-101 in mitigating CRS risk and maintaining a favorable safety profile, potentially revolutionizing VISTA-directed immunotherapy.
Interesting News
👀
專欄US Top Rating Updates on 10/3: WFC, ADBE, MU, STX and More
• $Box Inc(BOX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $CF工業控股(CF.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $135 (from $110)
• $New Gold(NGD.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $1.25 (from $1)
• $Sensei Biotherapeutics(SNSE.US)$: Oppenheimer Upgrades to Outperform from Perform - PT $5
• $Senetas Corp Ltd(SEN.AU)$ : Tru...
暫無評論